American Leprosy Missions, Inc. 
The information in this column was provided to MinistryWatch by the ministry itself. It was last updated 1/17/2020. To update the information in this column, please email: info@ministrywatch.com
Summary
American Leprosy Missions is the oldest and largest Christian, non-profit organization in the U.S. dedicated to curing and caring for people affected by leprosy and related diseases around the world. During its more than 100-year history, American Leprosy Missions has provided holistic care to more than four million people including medical treatment and training, medical supply deliveries, health system strengthening, research, community development, and disease mapping and management.
Contact information
Mailing address:
One Alm Way
Greenville, SC 29601-9948
Website: www.leprosy.org
Phone: (864) 271-7040
Email: amlep@leprosy.org
Organization details
EIN: 135562163
CEO/President: Mr. Bill Simmons
Chairman: Chris A. Hogue, M.B.A.
Board size: 11
Founder:
Year founded: 1906
Tax deductible: Yes
Fiscal year end: 06/30
Member of ECFA: Yes
Member of ECFA since: 1981
Purpose
More than one billion men, women and children are affected by neglected tropical diseases (NTDs), including leprosy and Buruli ulcer. These diseases affect the poorest and most neglected people and can lead to profound pain and suffering, lifelong disabilities, increased poverty, stigma and isolation.
For more than 100 years, the organization has acted as a channel of Christ's love, helping people suffering from these terrible diseases be healed and restored to lives of dignity and hope.
Today, American Leprosy Missions continues to lead a global fight against NTDs, working to cure and care for those affected, and actually end these devastating diseases in our time.
Mission statement
American Leprosy Missions' Mission Statement is:
American Leprosy Missions exists to serve as a channel of Christ's love to persons affected by leprosy and related diseases, helping them to be healed in body and spirit and restored to lives of dignity and hope.
Statement of faith
American Leprosy Missions uses the following to express its Statement of Faith (adopted from the National Association of Evangelicals):
1.We believe the Bible to be the inspired, the only infallible, authoritative Word of God.
2.We believe that there is one God, eternally existent in three persons; Father, Son, and Holy Spirit.
3.We believe in the deity of our Lord Jesus Christ, in His virgin birth, in His sinless life, in His miracles, in His vicarious and atoning death through His shed blood, in His bodily resurrection, in His ascension to the right hand of the Father, and in His personal return in power and glory.
4.We believe that for the salvation of lost and sinful man, regeneration by the Holy Spirit is absolutely essential, and that this salvation is received through faith in Jesus Christ as Savior and Lord and not as a result of good works.
5.We believe in the present ministry of the Holy Spirit by whose indwelling the Christian is enabled to live a godly life and to perform good works.
6.We believe in the resurrection of both the saved and the lost; they that are saved unto the resurrection of life and they that are lost unto the resurrection of damnation.
7.We believe in the spiritual unity of believers in our Lord Jesus Christ.
Transparency grade
A
To understand our transparency grade, click here.
Financial efficiency ratings
Sector: Relief and Development
| Category | Rating | Overall rank | Sector rank |
| Overall efficiency rating | | 810 of 817 | 69 of 69 |
| Fund acquisition rating | | 780 of 817 | 66 of 69 |
| Resource allocation rating | | 672 of 817 | 61 of 69 |
| Asset utilization rating | | 802 of 817 | 67 of 69 |
Financial ratios
| Funding ratios | Sector median | 2019 | 2018 | 2017 | 2016 | 2015 |
Return on fundraising efforts Return on fundraising efforts = Fundraising expense / Total contributions | 7% | 19% | 12% | 21% | 19% | 17% |
Fundraising cost ratio Fundraising cost ratio = Fundraising expense / Total revenue | 6% | 18% | 12% | 20% | 19% | 17% |
Contributions reliance Contributions reliance = Total contributions / Total revenue | 98% | 99% | 99% | 97% | 97% | 97% |
Fundraising expense ratio Fundraising expense ratio = Fundraising expense / Total expenses | 6% | 18% | 16% | 18% | 18% | 16% |
Other revenue reliance Other revenue reliance = Total other revenue / Total revenue | 2% | 1% | 1% | 3% | 3% | 3% |
| Operating ratios | Sector median | 2019 | 2018 | 2017 | 2016 | 2015 |
Program expense ratio Program expense ratio = Program services / Total expenses | 86% | 77% | 81% | 79% | 79% | 82% |
Spending ratio Spending ratio = Total expenses / Total revenue | 98% | 100% | 75% | 111% | 104% | 107% |
Program output ratio Program output ratio = Program services / Total revenue | 84% | 77% | 60% | 88% | 83% | 88% |
Savings ratio Savings ratio = Surplus (deficit) / Total revenue | 2% | 0% | 25% | -11% | -4% | -7% |
Reserve accumulation rate Reserve accumulation rate = Surplus (deficit) / Net assets | 5% | 0% | 31% | -13% | -5% | -7% |
General and admin ratio General and admin ratio = Management and general expense / Total expenses | 6% | 5% | 3% | 3% | 3% | 2% |
| Investing ratios | Sector median | 2019 | 2018 | 2017 | 2016 | 2015 |
Total asset turnover Total asset turnover = Total expenses / Total assets | 1.86 | 0.82 | 0.90 | 1.31 | 1.11 | 1.05 |
Degree of long-term investment Degree of long-term investment = Total assets / Total current assets | 1.37 | 13.98 | 28.70 | 18.51 | 13.71 | 22.34 |
Current asset turnover Current asset turnover = Total expenses / Total current assets | 2.93 | 11.47 | 25.82 | 24.22 | 15.28 | 23.56 |
| Liquidity ratios | Sector median | 2019 | 2018 | 2017 | 2016 | 2015 |
Current ratio Current ratio = Total current assets / Total current liabilities | 8.46 | 3.27 | 3.47 | 1.15 | 3.74 | 2.08 |
Current liabilities ratio Current liabilities ratio = Total current liabilities / Total current assets | 0.11 | 0.31 | 0.29 | 0.87 | 0.27 | 0.48 |
Liquid reserve level Liquid reserve level = (Total current assets - Total current liabilities) / (Total expenses / 12) | 3.07 | 0.73 | 0.33 | 0.06 | 0.58 | 0.26 |
| Solvency ratios | Sector median | 2019 | 2018 | 2017 | 2016 | 2015 |
Liabilities ratio Liabilities ratio = Total liabilities / Total assets | 12% | 3% | 2% | 7% | 4% | 4% |
Debt ratio Debt ratio = Debt / Total assets | 0% | 0% | 0% | 0% | 0% | 0% |
Reserve coverage ratio Reserve coverage ratio = Net assets / Total expenses | 42% | 118% | 109% | 71% | 86% | 91% |
Financials
| Balance sheet | |||||
| Assets | 2019 | 2018 | 2017 | 2016 | 2015 |
| Cash | $1,003,779 | $369,623 | $443,145 | $635,929 | $286,803 |
| Receivables, inventories, prepaids | $185,182 | $196,366 | $175,340 | $245,572 | $316,723 |
| Short-term investments | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $0 | $0 | $0 | $0 | $0 |
| Total current assets | $1,188,961 | $565,989 | $618,485 | $881,501 | $603,526 |
| Long-term investments | $9,129,114 | $9,431,996 | $4,938,142 | $5,760,660 | $7,057,782 |
| Fixed assets | $116,518 | $122,761 | $122,025 | $153,447 | $204,039 |
| Other long-term assets | $6,190,315 | $6,124,573 | $5,768,632 | $5,286,119 | $5,616,791 |
| Total long-term assets | $15,435,947 | $15,679,330 | $10,828,799 | $11,200,226 | $12,878,612 |
| Total assets | $16,624,908 | $16,245,319 | $11,447,284 | $12,081,727 | $13,482,138 |
| Liabilities | 2019 | 2018 | 2017 | 2016 | 2015 |
| Payables and accrued expenses | $196,169 | $162,950 | $538,506 | $234,426 | $286,407 |
| Other current liabilities | $167,851 | $0 | $0 | $1,385 | $3,089 |
| Total current liabilities | $364,020 | $162,950 | $538,506 | $235,811 | $289,496 |
| Debt | $0 | $0 | $0 | $0 | $0 |
| Due to (from) affiliates | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $134,329 | $142,685 | $246,281 | $276,359 | $308,881 |
| Total long-term liabilities | $134,329 | $142,685 | $246,281 | $276,359 | $308,881 |
| Total liabilities | $498,349 | $305,635 | $784,787 | $512,170 | $598,377 |
| Net assets | 2019 | 2018 | 2017 | 2016 | 2015 |
| Unrestricted | $8,713,791 | $8,647,824 | $3,532,940 | $5,027,876 | $6,011,573 |
| Temporarily restricted | $7,412,768 | $960,554 | $1,153,855 | $1,064,983 | $1,062,046 |
| Permanently restricted | $0 | $6,331,306 | $5,975,702 | $5,476,698 | $5,810,142 |
| Net assets | $16,126,559 | $15,939,684 | $10,662,497 | $11,569,557 | $12,883,761 |
| Revenues and expenses | |||||
| Revenue | 2019 | 2018 | 2017 | 2016 | 2015 |
| Total contributions | $13,465,316 | $19,277,069 | $13,123,786 | $12,529,567 | $12,853,642 |
| Program service revenue | $0 | $0 | $124,814 | $0 | $0 |
| Membership dues | $0 | $0 | $0 | $0 | $0 |
| Investment income | $118,702 | $205,927 | $291,522 | $399,648 | $416,212 |
| Other revenue | $8,348 | $1,180 | $2,331 | $2,187 | $8,263 |
| Total other revenue | $127,050 | $207,107 | $418,667 | $401,835 | $424,475 |
| Total revenue | $13,592,366 | $19,484,176 | $13,542,453 | $12,931,402 | $13,278,117 |
| Expenses | 2019 | 2018 | 2017 | 2016 | 2015 |
| Program services | $10,517,342 | $11,770,082 | $11,870,294 | $10,680,273 | $11,640,620 |
| Management and general | $621,326 | $499,083 | $415,799 | $387,027 | $345,818 |
| Fundraising | $2,503,629 | $2,345,410 | $2,694,358 | $2,398,148 | $2,234,960 |
| Total expenses | $13,642,297 | $14,614,575 | $14,980,451 | $13,465,448 | $14,221,398 |
| Change in net assets | 2019 | 2018 | 2017 | 2016 | 2015 |
| Surplus (deficit) | ($49,931) | $4,869,601 | ($1,437,998) | ($534,046) | ($943,281) |
| Other changes in net assets | $236,806 | $407,586 | $530,938 | ($780,158) | ($209,079) |
| Total change in net assets | $186,875 | $5,277,187 | ($907,060) | ($1,314,204) | ($1,152,360) |
Compensation
| Name | Title | Compensation |
| David W Simmons | President/CEO | $211,323 |
| Darren Schaupp | VP of Programs | $144,395 |
| James Oehrig | Chief Programs Officer | $136,011 |
| Beverly H Elmore | VP of Finance | $131,181 |
| Christina Miller-Colton | VP of Development | $121,077 |
| Sarah Hesshaus | VP of Bus. Process & Comm. | $112,171 |
| Stefanie Weiland | VP Special Initiatives | $26,947 |
Compensation data as of: 6/30/2019
Response from ministry
No response has been provided by this ministry.
The information below was provided to MinistryWatch by the ministry itself. It was last updated 1/17/2020. To update the information below, please email: info@ministrywatch.com
History
In 1906, a group of mission executives, ministers and businessmen met in New York City. Compelled by their faith and spurred by their compassion for some of the most marginalized and impoverished people in the world, these seven men founded what would become American Leprosy Missions.
During the early 1980s, American Leprosy Missions became one of the first organizations to use the new multi-drug therapy, a combination of three antibiotics, to cure leprosy.
During the early 1980s, American Leprosy Missions became one of the first organizations to use the new multi-drug therapy, a combination of three antibiotics, to cure leprosy.
In 2002, the organization began development of the world's first leprosy-specific vaccine.
Today American Leprosy Missions partners with more than 50 organizations around the world on policy development, program coordination, innovative research, advocacy, technical training, community development and more, in order to best serve people affected by leprosy and related diseases.
More information at: www.leprosy.org/leprosy-history
Program accomplishments
In 2019, partners like you helped relieve suffering and restore hope to more than 200,000 men, women and children around the world.
- 2,983 pairs of special footwear distributed
- 61,842 people screened for NTDs
- $5,408,051 worth of critical medicines and medical supplies sent to Central African Republic and Nepal
- 4,372 toilets constructed in India and Nepal
- 5,149 nerve function tests administered
- $510,067 invested in pioneering research in 18 countries.
- 25,749 households reached with education on sanitation, hygiene and NTDs
- 2,442 patients received wound care treatment
- 1 leprosy vaccine successfully completed Phase Ia clinical trial
Needs
It costs just $348 to cure and care for one person suffering from leprosy. This includes medical treatment, health worker training, medicine, reconstructive surgery and more.